Background: Chemotherapy-related cognitive impairment refers to a cluster of symptoms commonly referred to as “chemobrain”. To date, nursing literature on the progression of and tools used to evaluate chemobrain is limited. Objectives: The purpose of this pilot study was to explore the onset of...
Background: Chemotherapy-induced peripheral neuropathy (CIPN) is a debilitating and degenerative side effect of many commonly used chemotherapy agents. Symptoms manifest as sensory and motor neuropathies. CIPN may necessitate chemotherapy dose reduction or discontinuation. Objectives: This review...
Ms. M is a 31-year-old female with metastatic osteogenic sarcoma. She has received multiple chemotherapeutic agents in the past, including cisplatin, and has experienced periodic disease-free intervals. She has no evidence of abdominal disease and no prior nephrectomy.
Purpose/Objectives: To document weight gain in women treated with adjuvant chemotherapy for early-stage breast cancer and to examine the relationship of weight gain and perceived quality of life (QOL). Design: Descriptive, correlational study. Setting: Data collected in three settings: an...
